DermTech Seeks to Tackle Melanoma Testing with Genomic Technology | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – Looking to tap into what its chief executive said may be the biggest market for genetic testing in the world, DermTech International is progressing in developing a test that it claims is more accurate than any melanoma detection test currently available.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.